Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nader Rifai

Showing results (61-70 of 327) with videos related to

Pageof 33
Sort By:
The American Journal of Medicine|August 7, 2007
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic womenAruna D Pradhan, Nader Rifai, Julie E Buring, et al.
Atherosclerosis|June 20, 2006
Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetesLu Qi, Simin Liu, Nader Rifai, et al.
JAMA|September 21, 2006
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy womenJacqueline Suk Danik, Nader Rifai, Julie E Buring, et al.
Circulation|November 26, 2003
Blood pressure, C-reactive protein, and risk of future cardiovascular eventsGavin J Blake, Nader Rifai, Julie E Buring, et al.
European Heart Journal|October 18, 2003
Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trialGavin J Blake, Michelle A Albert, Nader Rifai, et al.
JAMA|February 6, 2004
C-reactive protein and the risk of incident colorectal cancerThomas P Erlinger, Elizabeth A Platz, Nader Rifai, et al.
Clinical Chemistry|December 26, 2001
Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratoryG Russell Warnick, Gary L Myers, Gerald R Cooper, et al.
Circulation|January 29, 2003
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American womenPaul M Ridker, Julie E Buring, Nancy R Cook, et al.
JAMA|February 15, 2007
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk ScorePaul M Ridker, Julie E Buring, Nader Rifai, et al.
Clinical Chemistry|August 12, 2018
Learning in the 21st Century: Concepts and ToolsNader Rifai, Todd Rose, Graham T McMahon, et al.
Pageof 33

Showing results (61-70 of 327) with videos related to

Sort By:
Pageof 33
The American Journal of Medicine|August 7, 2007
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic womenAruna D Pradhan, Nader Rifai, Julie E Buring, et al.
Atherosclerosis|June 20, 2006
Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetesLu Qi, Simin Liu, Nader Rifai, et al.
JAMA|September 21, 2006
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy womenJacqueline Suk Danik, Nader Rifai, Julie E Buring, et al.
Circulation|November 26, 2003
Blood pressure, C-reactive protein, and risk of future cardiovascular eventsGavin J Blake, Nader Rifai, Julie E Buring, et al.
European Heart Journal|October 18, 2003
Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trialGavin J Blake, Michelle A Albert, Nader Rifai, et al.
JAMA|February 6, 2004
C-reactive protein and the risk of incident colorectal cancerThomas P Erlinger, Elizabeth A Platz, Nader Rifai, et al.
Clinical Chemistry|December 26, 2001
Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratoryG Russell Warnick, Gary L Myers, Gerald R Cooper, et al.
Circulation|January 29, 2003
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American womenPaul M Ridker, Julie E Buring, Nancy R Cook, et al.
JAMA|February 15, 2007
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk ScorePaul M Ridker, Julie E Buring, Nader Rifai, et al.
Clinical Chemistry|August 12, 2018
Learning in the 21st Century: Concepts and ToolsNader Rifai, Todd Rose, Graham T McMahon, et al.
Pageof 33